alphaveCOHANCE₹444.00

Cohance Lifesciences Ltd.

₹ CrorePeersDIVISLAB SYNGENE ASTERDM LALPATHLAB NATCOPHARM WOCKPHARMA NEULANDLAB NHMcap ₹16,987 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	567.2	995.2	1,990.1	1,990.1
+ Capital Work-in-Progress	179.0	254.8	173.2	173.2
+ Goodwill	0.0	655.1	1,283.7	1,283.7
+ Other Intangibles	102.4	63.1	95.0	95.0
+ Intangibles under Development	0.1	0.8	4.5	4.5
+ Non-current Investments	130.6	145.0	262.2	262.2
+ Long-term Loans	0.0	4.6	1.3	1.3
+ Other Non-current Financial Assets	9.4	18.6	32.4	32.4
Non-current Financial Assets	140.0	168.1	296.0	296.0
+ Deferred Tax Assets	—	0.6	2.6	2.6
+ Other Non-current Assets	2.2	5.5	56.6	56.6
Total Non-current Assets	990.9	2,143.2	3,901.7	3,901.7
Current Assets
+ Inventories	231.2	166.6	562.2	562.2
+ Current Investments	773.9	191.7	266.3	266.3
+ Trade Receivables	133.7	284.4	681.0	681.0
+ Cash & Cash Equivalents	47.2	85.4	49.1	49.1
+ Other Bank Balances	3.3	3.3	10.5	10.5
+ Short-term Loans	0.8	0.4	8.0	8.0
+ Other Current Financial Assets	0.4	10.0	1.8	1.8
Current Financial Assets	959.3	575.2	1,016.8	1,016.8
+ Other Current Assets	62.7	111.5	217.2	217.2
Total Current Assets	1,263.2	853.3	1,796.3	1,796.3
Total Assets	2,254.1	3,031.8	5,729.6	5,729.6
Equity
+ Equity Share Capital	25.5	25.5	38.3	38.3
+ Other Equity / Reserves	2,025.2	1,671.1	3,873.0	3,873.0
Equity — Owners of Parent	2,050.7	1,696.6	3,911.3	3,911.3
+ Minority Interest	—	144.1	122.5	122.5
Total Equity	2,050.7	1,840.6	4,033.8	4,033.8
Liabilities
+ Borrowings — Non-current	0.0	6.2	50.5	50.5
+ Other Non-current Financial Liab	21.2	728.4	901.1	901.1
Non-current Financial Liabilities	21.2	734.7	951.6	951.6
+ Provisions — Non-current	10.5	0.3	0.4	0.4
+ Deferred Tax Liabilities	64.8	91.0	97.9	97.9
Non-current Liabilities	96.5	825.9	1,049.9	1,049.9
+ Borrowings — Current	38.6	71.9	119.2	119.2
+ Trade Payables	42.4	80.2	284.6	284.6
+ Other Current Financial Liab	14.0	187.1	119.0	119.0
Current Financial Liabilities	95.0	339.2	522.8	522.8
+ Provisions — Current	4.7	17.9	47.3	47.3
+ Current Tax Liabilities	0.0	1.1	16.4	16.4
+ Other Current Liabilities	7.2	7.1	59.4	59.4
Current Liabilities	106.9	365.2	645.9	645.9
Total Liabilities	203.4	1,191.1	1,695.8	1,695.8
Total Equity & Liabilities	2,254.1	3,031.8	5,729.6	5,729.6
Assets — additional as-filed lines
+ Non-current Assets Held for Sale	0.0	35.3	31.7	31.7
+ Current Tax Assets	10.0	0.0	0.1	0.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	11.7	45.3	45.3
+ Dues to Other Creditors — Current	—	68.5	239.3	239.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.